Global Wealth Strategies & Associates’s AbbVie ABBV Stock Holding History

Global Wealth Strategies & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Sell	1,329 -42	-3%	-$9.04K	0.06%	70
2026 Q1	$298K	Sell	1,371 -66	-5%	-$14.6K	0.07%	64
2025 Q4	$328K	Buy	1,437 +452	+46%	+$103K	0.08%	57
2025 Q3	$228K	Buy	985 +733	+291%	+$149K	0.06%	67
2025 Q2	$46.8K	Hold	252	–	–	0.01%	119
2025 Q1	$52.8K	Sell	252 -220	-47%	-$42.8K	0.02%	112
2024 Q4	$83.9K	Buy	472 +34	+8%	+$6.25K	0.03%	80
2024 Q3	$86.5K	Buy	438 +20	+5%	+$3.73K	0.03%	67
2024 Q2	$71.7K	Hold	418	–	–	0.03%	72
2024 Q1	$76.1K	Hold	418	–	–	0.03%	68
2023 Q4	$64.8K	Hold	418	–	–	0.03%	71
2023 Q3	$62.3K	Hold	418	–	–	0.03%	69
2023 Q2	$56.3K	Hold	418	–	–	0.03%	73
2023 Q1	$66.6K	Hold	418	–	–	0.03%	66
2022 Q4	$67.6K	Buy	+418	New	+$64.1K	0.04%	69

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Global Wealth Strategies & Associates's ABBV Position: Q2 2026 in Review

Global Wealth Strategies & Associates reduced its AbbVie (ABBV) stake by 3.1% in Q2 2026, selling an estimated $9.04K and leaving 1,329 shares worth $334K. The position accounts for 0.06% of the portfolio, ranked #70.

Global Wealth Strategies & Associates first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Global Wealth Strategies & Associates held 1,329 shares of AbbVie worth $334K as of Q2 2026.
Global Wealth Strategies & Associates sold 42 AbbVie shares in Q2 2026, an estimated $9.04K.
AbbVie made up 0.06% of Global Wealth Strategies & Associates's portfolio in Q2 2026, its #70 holding.
Global Wealth Strategies & Associates first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.